Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1029-1042
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1029
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1029
Table 3 Summary of the studies evaluating the role of indocyanine green to detect peritoneal carcinomatosis
Ref. | Yr | Patients | Nodules | Additional nodules | Sensitivity | Specificity | Considerations |
Liberale et al[95], 2020 | 2016 | 14 | 63 | 21.4% | 87.5% | 100% | |
Barabino et al[96], 2020 | 2016 | 10 | 88 | 72.4% | 77.3% | ||
Filippello et al[97], 2020 | 2016 | 10 | 29 | 65% | 57.1% | Same patients than Barabino et al[96], but comparing the use of bevacizumab or not | |
Lieto et al[100], 2020 | 2018 | 4 | 69 | 16 | 96.9% | 75% | ICG adds 25% of diagnostic improvement |
Sluiter et al[104], 2020 | 2019 | 28 | 169 | 80% | 74.8% | NBI increases sensitivity from 80% to 96% when compared with white light, with the same specificity |
- Citation: Martínez-López E, Martínez-Pérez A, Navarro-Martínez S, Sebastián-Tomás JC, de'Angelis N, García-Granero E. Real-time fluorescence image-guided gastrointestinal oncologic surgery: Towards a new era. World J Gastrointest Oncol 2021; 13(9): 1029-1042
- URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1029.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.1029